- 期刊
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
延伸閱讀
- Boudadi, K., & Antonarakis, E. S. (2016). Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer. Clinical Medicine Insights: Oncology, (), 1-9. https://doi.org/10.4137/CMO.S34534
- 于大雄、朱燦銘（1995）。Recent Advances in Prostate Specific Antigen (PSA) and Prostate Cancer。中華民國泌尿科醫學會雜誌，6(3)，139-146。https://doi.org/10.7024/JUAROC.199509.0139
- Patel, J. C., Maughan, B. L., Agarwal, A. M., Batten, J. A., Zhang, T. Y., & Agarwal, N. (2013). Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer. Prostate Cancer, 2013(), 200-211. https://doi.org/10.1155/2013/981684
- Amaral, T. M. S., Macedo, D., Fernandes, I., & Costa, L. (2012). Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment. Prostate Cancer, 2012(), 80-90. https://doi.org/10.1155/2012/327253
- 李燕鳴（2012）。Accurate Use of Serum Prostate Specific Antigen in Detection of Early Prostate Cancer。台灣老年醫學暨老年學雜誌，7(4)，209-216。https://doi.org/10.29461/TGG.201211.0001